Currently, different therapies on how to combat this deadly disease has been built on developing prognostic and predictive tools based on the status of lymph nodes, the size and grade of tumour, hormone receptors, and human epidermal growth factor receptor 2 (HER2) expression [2]. Here, ERBB2 is linked to neoplasm.